S MIRON
Overview
Explore the profile of S MIRON including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shapira M, Resnick I, Bitan M, Ackerstein A, Tsirigotis P, Gesundheit B, et al.
Bone Marrow Transplant
. 2005 Oct;
36(12):1097-101.
PMID: 16247429
We evaluated the effect of alefacept (Amevive), a novel dimeric fusion protein, in steroid resistant/dependent acute graft-versus-host-disease (aGVHD). Seven patients were treated in eight aGVHD episodes. GVHD grade at treatment...
2.
Shapira M, Resnick I, Bitan M, Ackerstein A, Samuel S, Elad S, et al.
Bone Marrow Transplant
. 2004 Jul;
34(2):155-9.
PMID: 15235577
Historically, age >60 years was considered a contraindication for allogeneic stem cell transplantation (allo-SCT). In recent years, elderly (>60 years) patients have become eligible for allo-SCT due to the application...
3.
Shapira M, Or R, Resnick I, Bitan M, Ackerstein A, Samuel S, et al.
Bone Marrow Transplant
. 2003 Sep;
32(6):557-61.
PMID: 12953126
Nonmyeloblative stem cell transplantation (NST, SCT) aims to induce host-versus-graft tolerance for subsequent immunotherapy of underlying disease with alloreactive donor lymphocytes, focusing on well-tolerated conditioning suitable for elderly individuals or...
4.
Goldberg-Zimring D, Azhari H, MIRON S, Achiron A
Magn Reson Med
. 2001 Oct;
46(4):756-66.
PMID: 11590652
A new approach to approximate the 3-D shape of multiple sclerosis (MS) lesions and to calculate their volumes is presented. The suggested method utilizes sets of MS lesion contours taken...
5.
MIRON S, Borza T, Saveanu C, Gilles A, Barzu O, Craescu C
J Biomol NMR
. 2001 Aug;
20(3):287-8.
PMID: 11519751
No abstract available.
6.
MIRON S, Munier-Lehmann H, Craescu C
J Biomol NMR
. 2001 Mar;
19(1):89-90.
PMID: 11246863
No abstract available.
7.
Achiron A, MIRON S
Mult Scler
. 2001 Feb;
6 Suppl 2:S6-8; discussion S33.
PMID: 11188777
Intravenously administered immunoglobulins (IgG) treatment has several modes of action that can regulate the immune response during different steps of the inflammatory process in experimental autoimmune encephalomyelitis (EAE) and Multiple...
8.
Bank I, Hardan I, Lokshin E, Nas D, MIRON S, Ohad D, et al.
Immunobiology
. 2000 Oct;
202(3):239-53.
PMID: 11045660
In mice, monoclonal antibody (mAb) to the alpha1 integrin abrogate gastro-intestinal damage during graft-versus-host-disease (GVHD), suggesting anti alpha1 mAb as candidates for treatment in humans as well. Our current data...
9.
Mazzola C, MIRON S, Jenkins A
J Anal Toxicol
. 2000 Oct;
24(7):638-41.
PMID: 11043672
Loxapine is a dibenzoxazepine tricyclic compound used to treat schizophrenia in the United States since 1976. Metabolism includes demethylation to its primary metabolite, amoxapine. There are few documented reports of...
10.
Achiron A, Mor F, Margalit R, Cohen I, Lider O, MIRON S
J Autoimmun
. 2000 Oct;
15(3):323-30.
PMID: 11040073
Experimental autoimmune encephalomyelitis (EAE) was induced in Lewis rats either by active immunization with myelin basic protein (MBP) or by adoptive transfer using anti-MBP specific CD4(+)T cells. Treatment with human...